Studies have shown that ALKBH5 is overexpressed and m6A modification levels are reduced in ovarian cancer with lymph node metastasis and that the ALKBH5/m6A-ITGB1/FAK signalling axis plays an important role in ovarian cancer lymphangiogenesis and lymph node metastasis [136]. Here, PTK2 is linked to ovarian cancer.